Free Trial

TruBridge (TBRG) Projected to Post Quarterly Earnings on Thursday

TruBridge logo with Medical background

Key Points

  • TruBridge (NASDAQ:TBRG) is set to report its Q2 2025 earnings on Thursday, August 7th, with expectations for earnings of $0.29 per share and revenue of $86.68 million.
  • The company previously reported Q1 results on May 9th, missing earnings estimates with $0.29 per share but exceeding revenue expectations at $87.21 million.
  • TruBridge shares have seen a 1.3% decline recently, closing at $20.54, with institutional investors holding 88.64% of the stock.
  • Looking to export and analyze TruBridge data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

TruBridge (NASDAQ:TBRG - Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of $0.29 per share and revenue of $86.68 million for the quarter.

TruBridge (NASDAQ:TBRG - Get Free Report) last released its earnings results on Friday, May 9th. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.08). TruBridge had a positive return on equity of 0.33% and a negative net margin of 5.86%. The company had revenue of $87.21 million during the quarter, compared to analysts' expectations of $86.21 million. On average, analysts expect TruBridge to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

TruBridge Stock Down 1.9%

Shares of TBRG traded down $0.40 during mid-day trading on Tuesday, hitting $20.83. 28,599 shares of the company's stock were exchanged, compared to its average volume of 170,156. The firm has a fifty day moving average of $22.91 and a two-hundred day moving average of $25.02. TruBridge has a twelve month low of $9.83 and a twelve month high of $32.00. The stock has a market cap of $312.85 million, a price-to-earnings ratio of -15.43 and a beta of 0.59. The company has a quick ratio of 1.68, a current ratio of 1.69 and a debt-to-equity ratio of 0.98.

Analyst Ratings Changes

Separately, Stephens reiterated an "equal weight" rating and issued a $28.00 target price on shares of TruBridge in a research note on Thursday, April 10th.

Check Out Our Latest Research Report on TBRG

Insider Activity at TruBridge

In other news, CEO Christopher L. Fowler sold 6,000 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $25.05, for a total transaction of $150,300.00. Following the completion of the transaction, the chief executive officer directly owned 131,090 shares of the company's stock, valued at approximately $3,283,804.50. This trade represents a 4.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 10.70% of the company's stock.

Hedge Funds Weigh In On TruBridge

Several institutional investors have recently added to or reduced their stakes in TBRG. Millennium Management LLC increased its position in TruBridge by 20.9% in the 1st quarter. Millennium Management LLC now owns 226,172 shares of the company's stock valued at $6,224,000 after acquiring an additional 39,090 shares in the last quarter. Goldman Sachs Group Inc. increased its position in TruBridge by 31.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 152,668 shares of the company's stock valued at $4,201,000 after acquiring an additional 36,838 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in TruBridge in the 1st quarter valued at about $221,000. 88.64% of the stock is owned by institutional investors.

TruBridge Company Profile

(Get Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Featured Articles

Earnings History for TruBridge (NASDAQ:TBRG)

Should You Invest $1,000 in TruBridge Right Now?

Before you consider TruBridge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.

While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines